ReproCell Inc (4978)

Currency in JPY
159.0
+1.0(+0.63%)
Closed·
Earnings results expected in 12 days
4978 is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
156.0161.0
52 wk Range
106.0277.0
Key Statistics
Bid/Ask
159.00 / 161.00
Prev. Close
158
Open
156
Day's Range
156-161
52 wk Range
106-277
Volume
536.2K
Average Volume (3m)
795.6K
1-Year Change
43.2432%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
4978 Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Liquid assets exceed short term obligations

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell

ReproCell Inc Company Profile

ReproCELL Incorporated provides stem cell research and drug discovery services in Japan. It offers stem cell reagents, including RNA reprogramming, small molecules, growth factors and cytokines, antibodies and staining kits, cell substrates, cryopreservation media, dissociation solution, and transfection reagents; differentiated induced pluripotent stem cell (iPSC) and related reagents, feeder cells, pluripotent stem cells, StemEdit gene edited iPSCs, mesenchymal stem cells (MSCs), and new immortalized cell lines and related reagents; and iPSC-derived exosomes. The company also provides Alvetex 3D, a cell culture system; Alvetex, an advanced tissue bioengineering system; EZSPHERE Multiwell Dishes and Plates; KOKEN atelocollagen; ABLE Biott bioreactor systems; and 2mag stirrer systems. In addition, It offers research stem cell, genomics, clinical stem cell research, preclinical and drug discovery CRO, precision medicine, human tissue samples, clinical laboratory, and gene editing services. ReproCELL Incorporated was incorporated in 2003 and is based in Yokohama, Japan.

Employees
99
Market
Japan

Compare 4978 to Peers and Sector

Metrics to compare
4978
Peers
Sector
Relationship
P/E Ratio
−54.0x−8.0x−0.6x
PEG Ratio
1.570.020.00
Price/Book
1.7x3.1x2.6x
Price / LTM Sales
5.7x16.9x3.4x
Upside (Analyst Target)
-55.6%44.9%
Fair Value Upside
Unlock17.5%6.7%Unlock
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate

Earnings

Latest Release
Nov 13, 2025
EPS / Forecast
-1.93 / --
Revenue / Forecast
499.00M / --
EPS Revisions
Last 90 days

4978 Income Statement

FAQ

What Stock Exchange Does ReproCell Trade On?

ReproCell is listed and trades on the Tokyo Stock Exchange stock exchange.

What Is the Stock Symbol for ReproCell?

The stock symbol for ReproCell is "4978."

What Is the ReproCell Market Cap?

As of today, ReproCell market cap is 15.06B.

What Is ReproCell's Earnings Per Share (TTM)?

The ReproCell EPS (TTM) is -2.95.

When Is the Next ReproCell Earnings Date?

ReproCell will release its next earnings report on 11 Feb 2026.

From a Technical Analysis Perspective, Is 4978 a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.

How Many Times Has ReproCell Stock Split?

ReproCell has split 1 times.

How Many Employees Does ReproCell Have?

ReproCell has 99 employees.

What is the current trading status of ReproCell (4978)?

As of 31 Jan 2026, ReproCell (4978) is trading at a price of 159.0, with a previous close of 158.0. The stock has fluctuated within a day range of 156.0 to 161.0, while its 52-week range spans from 106.0 to 277.0.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2026 - Fusion Media Limited. All Rights Reserved.